|
Aug 6
|
Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
|
|
Jul 25
|
Context Therapeutics Presents CTIM-76 Phase 1 Trial in Progress at ASCO 2025
|
|
May 12
|
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
May 7
|
Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
|